Robbins & Myers

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

Nearest Resistance: $60

Nearest Support: N/A

Catalyst: Merger Agreement

One small-cap stock that's getting plenty of attention today is Robbins & Myers ( RBN), a firm that announced a merger agreement with National-Oilwell Varco ( NOV), the latter paying $60 per share in cash for each share of RBN. While that's spiking trading volume in RBN, there isn't a trade to be made here.

Unless you're trying to vie for the 38 cents per share in merger arbitrage opportunity that's currently priced into RBN.

To see these stocks in action, check out the at Most-Active Stocks portfolio on Stockpickr.

-- Written by Jonas Elmerraji in Baltimore.

RELATED LINKS:



Follow Stockpickr on Twitter and become a fan on Facebook.
At the time of publication, author had no positions in stocks mentioned.

Jonas Elmerraji is the editor and portfolio manager of the Rhino Stock Report, a free investment advisory that returned 15% in 2008. He is a contributor to numerous financial outlets, including Forbes and Investopedia, and has been featured in Investor's Business Daily, in Consumer's Digest and on MSNBC.com.

If you liked this article you might like

Biotech Movers: Disappointment for Bristol-Myers Kidney Combo Boosts Exelixis

Carnival, Tableau Software, Groupon, Newell Brands: 'Mad Money' Lightning Round

Market Stands at a Make-Or-Break Level: Cramer's 'Mad Money' Recap (Monday 7/17/17)

Exelixis Has an Enviable Chart Pattern

Biotech Movers: Exelixis, Omeros, Inovio